CH640870A5 - Verfahren zur herstellung von 9-desacetyl-9-formyl-n-trifluoracetyldaunorubicin. - Google Patents
Verfahren zur herstellung von 9-desacetyl-9-formyl-n-trifluoracetyldaunorubicin. Download PDFInfo
- Publication number
- CH640870A5 CH640870A5 CH692582A CH1580777A CH640870A5 CH 640870 A5 CH640870 A5 CH 640870A5 CH 692582 A CH692582 A CH 692582A CH 1580777 A CH1580777 A CH 1580777A CH 640870 A5 CH640870 A5 CH 640870A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formyl
- trifluoroacetyl
- dihydrodoxorubicin
- deacetyl
- solution
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- NKZRZOVSJNSBFR-UHFFFAOYSA-N Doxorubicinol Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(O)CO)CC1OC1CC(N)C(O)C(C)O1 NKZRZOVSJNSBFR-UHFFFAOYSA-N 0.000 claims description 3
- NKZRZOVSJNSBFR-FEMMEMONSA-N doxorubicinol Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)[C@@H](O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 NKZRZOVSJNSBFR-FEMMEMONSA-N 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- VOASREXNXKOKBP-HWJSKKJZSA-N n-[(2s,3s,4s,6r)-6-[[(1s,3s)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1 VOASREXNXKOKBP-HWJSKKJZSA-N 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000243 solution Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
- OAIVIYSBZFEOIU-UHFFFAOYSA-N chloroform;propan-2-one Chemical compound CC(C)=O.ClC(Cl)Cl OAIVIYSBZFEOIU-UHFFFAOYSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005583 trifluoroacetylation reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB53455/76A GB1542920A (en) | 1976-12-22 | 1976-12-22 | Antitumour glycosides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH640870A5 true CH640870A5 (de) | 1984-01-31 |
Family
ID=10467876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH692582A CH640870A5 (de) | 1976-12-22 | 1977-12-21 | Verfahren zur herstellung von 9-desacetyl-9-formyl-n-trifluoracetyldaunorubicin. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4146616A (show.php) |
| JP (1) | JPS5379852A (show.php) |
| AT (1) | AT355720B (show.php) |
| AU (1) | AU518245B2 (show.php) |
| BE (1) | BE862103A (show.php) |
| CA (1) | CA1080703A (show.php) |
| CH (1) | CH640870A5 (show.php) |
| DE (1) | DE2757057A1 (show.php) |
| DK (1) | DK564677A (show.php) |
| FR (1) | FR2375251A1 (show.php) |
| GB (1) | GB1542920A (show.php) |
| IE (1) | IE46122B1 (show.php) |
| NL (1) | NL7713906A (show.php) |
| NZ (1) | NZ186048A (show.php) |
| SE (1) | SE7714465L (show.php) |
| YU (1) | YU301277A (show.php) |
| ZA (1) | ZA777556B (show.php) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5543012A (en) * | 1978-09-20 | 1980-03-26 | Sanraku Inc | Novel anthracycline derivatine and its preparation |
| US4254110A (en) * | 1979-02-02 | 1981-03-03 | Farmitalia Carlo Erba S.P.A. | Pentofuranosyl anthracyclines, intermediates in and method for their preparation and compositions and use thereof |
| US4604381A (en) * | 1982-07-16 | 1986-08-05 | Farmitalia Carlo Erba S.P.A. | 4-demethoxy-13-dihydrodaunorubicin and use thereof |
| FR2560876B1 (fr) * | 1984-03-09 | 1987-01-16 | Hoechst Lab | Nouvelles anthracyclinones, leur procede de preparation, nouveaux glycosides (anthracyclines) obtenus a partir de ces anthracyclinones, utilisation de ces glycosides en tant que medicaments |
| FR2584406B1 (fr) * | 1985-07-02 | 1988-09-09 | Hoechst Lab | Nouvelles tetralines, leurs procedes de preparation, leur utilisation pour la preparation des anthracyclinones et nouveaux glycosides (anthracyclines) obtenus a partir de ces anthracyclinones |
| DE3641835A1 (de) * | 1986-12-08 | 1988-06-16 | Behringwerke Ag | Zytostatisch wirksame anthracyclinderivate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4020270A (en) * | 1974-05-02 | 1977-04-26 | Societa' Farmaceutici Italia S.P.A. | L-lyxohex-1-enopyranose derivative |
-
1976
- 1976-12-22 GB GB53455/76A patent/GB1542920A/en not_active Expired
-
1977
- 1977-12-14 US US05/860,448 patent/US4146616A/en not_active Expired - Lifetime
- 1977-12-15 NL NL7713906A patent/NL7713906A/xx not_active Application Discontinuation
- 1977-12-19 DK DK564677A patent/DK564677A/da not_active Application Discontinuation
- 1977-12-19 IE IE2578/77A patent/IE46122B1/en unknown
- 1977-12-19 YU YU03012/77A patent/YU301277A/xx unknown
- 1977-12-19 AU AU31749/77A patent/AU518245B2/en not_active Expired
- 1977-12-19 SE SE7714465A patent/SE7714465L/xx not_active Application Discontinuation
- 1977-12-19 AT AT907477A patent/AT355720B/de not_active IP Right Cessation
- 1977-12-19 FR FR7738200A patent/FR2375251A1/fr active Granted
- 1977-12-20 ZA ZA00777556A patent/ZA777556B/xx unknown
- 1977-12-20 NZ NZ186048A patent/NZ186048A/xx unknown
- 1977-12-21 JP JP15424777A patent/JPS5379852A/ja active Pending
- 1977-12-21 CA CA293,544A patent/CA1080703A/en not_active Expired
- 1977-12-21 BE BE183665A patent/BE862103A/xx unknown
- 1977-12-21 CH CH692582A patent/CH640870A5/de not_active IP Right Cessation
- 1977-12-21 DE DE19772757057 patent/DE2757057A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA1080703A (en) | 1980-07-01 |
| JPS5379852A (en) | 1978-07-14 |
| US4146616A (en) | 1979-03-27 |
| IE46122L (en) | 1978-06-22 |
| NL7713906A (nl) | 1978-06-26 |
| YU301277A (en) | 1982-06-30 |
| FR2375251A1 (fr) | 1978-07-21 |
| AT355720B (de) | 1980-03-25 |
| AU518245B2 (en) | 1981-09-24 |
| DE2757057A1 (de) | 1978-07-06 |
| DK564677A (da) | 1978-06-23 |
| NZ186048A (en) | 1980-05-08 |
| BE862103A (fr) | 1978-04-14 |
| AU3174977A (en) | 1979-06-28 |
| ATA907477A (de) | 1979-08-15 |
| FR2375251B1 (show.php) | 1981-11-13 |
| IE46122B1 (en) | 1983-02-23 |
| ZA777556B (en) | 1978-09-27 |
| SE7714465L (sv) | 1978-06-23 |
| GB1542920A (en) | 1979-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3012533C2 (show.php) | ||
| EP0030295B1 (de) | Verfahren zur Herstellung von 4'-Epidaunorubicin, 3',4'-Diepidaunorubicin, hierbei entstehende Zwischenprodukte sowie deren Verwendung | |
| DE2432644A1 (de) | Derivate von desoxystreptamin enthaltenden aminoglykosid-antibiotikumderivaten und verfahren zu ihrer herstellung | |
| DE3719377C2 (de) | Anthracyclinglykoside, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten | |
| CH640870A5 (de) | Verfahren zur herstellung von 9-desacetyl-9-formyl-n-trifluoracetyldaunorubicin. | |
| DE1958514C3 (de) | Apovincaminsaureamid | |
| DE2517293C2 (de) | Neue Cardenolid-β-Glykoside, ihre Herstellung und Verwendung | |
| DE2453649A1 (de) | Verfahren zur herstellung von coformycin | |
| DE2918291A1 (de) | Neue substituierte antitumoranthracycline und verfahren zu deren herstellung | |
| DE1961947A1 (de) | 6,7-Diacyloxy-tetrahydroisochinolinverbindungen und Verfahren zu ihrer Herstellung | |
| CH632769A5 (de) | Verfahren zur herstellung von anthracyclinen. | |
| DE2902292C2 (de) | Verfahren zur Herstellung von 2,4-Diaminobuttersäure oder 4-Amino-2-hydroxybuttersäure | |
| CH640542A5 (de) | Deoxyanthracycline. | |
| DE2306580C2 (de) | Verfahren zur Herstellung von 16-Acylderivaten des Gitoxigenindigitoxosids | |
| DE2661027C2 (show.php) | ||
| AT274249B (de) | Verfahren zur Herstellung des neuen Scilliglaucosidin-19-ol-α-L-rhamnosids | |
| DE2924334C2 (show.php) | ||
| DE1793690C3 (de) | 1 S-Hydroxy-9-oxoprosta-5-cis-10,13trans-triensäure und deren Salze sowie Verfahren zu ihrer Herstellung | |
| AT242871B (de) | Verfahren zur Herstellung von neuen 3-Keto-Δ<4,6>-6-trifluormethylsteroiden und 3-Keto-Δ<1,4,6>-6-trifluormethylsteroiden | |
| DE2833967A1 (de) | Verfahren zur herstellung von apovincamin | |
| DE1470196C (de) | 1 Hydroxymethyl colchicindenvate und Verfahren zu ihrer Herstellung | |
| DE1024948B (de) | Verfahren zur Herstellung von 2-Amino-2-desoxy-aldohexosen und deren Salzen | |
| DE1165605B (de) | Verfahren zur Herstellung von Alkylestern des Antibiotikums BA-163 | |
| DE2734459A1 (de) | Peruvosid-derivate und verfahren zu ihrer herstellung | |
| WO1995006655A1 (de) | (glycosylamid)-uronsäure-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |